Discover a rapid and reliable tool for the identification and characterization of STING-targeting compounds.
- Quantifying human IFN-β using an HTRF-based approach.
- This note demonstrates how using HTRF to quantify human IFN-β is a powerful and effective method for the characterization of STING agonists.
- It provides data demonstrating that the quantification of IFN-β using HTRF is well correlated with ELISA assays.
- This note also provides data about gene reporter assay correlation with our HTRF IFN-β assay.
For research use only. Not for use in diagnostic procedures.